October starts this Thursday and it’s a special month to Color Genomics. This marks our first Breast Cancer Awareness Month since our launch in April. Breast Cancer Awareness Month has become an annual international health campaign organized by major breast cancer charities every October to increase awareness of the disease and raise funds for research into the disease’s cause, prevention, diagnosis, treatment and cure.
October has become the month of pink — pink products, NFL teams wearing pink, pink-branded fundraising events, pink ad campaigns and more. The pink comes from the late Evelyn Lauder of the Estée Lauder Companies, who founded The Breast Cancer Research Foundation and established the pink ribbon as its symbol over a decade ago.
At Color Genomics, we will be showing our pink spirit this October and supporting this important cause. In order to increase access to genetic testing and support the breast cancer community, we are providing Color at the special price of $199 during Breast Cancer Awareness Month. This is a sign of our commitment to ensuring that every individual has the opportunity to understand their genetic risk of breast cancer in a responsible and well-supported way through a physician-ordered test and access to board-certified genetic counselors.
Until recently, genetic testing for breast and ovarian cancer risk was up to $4,000 per test. At $199, up to twenty individuals can get tested in October for what it would have cost to test a single individual a few years ago. Information from a genetic test can have a profound impact on an individual’s health. About 10–15% of breast and ovarian cancers are due to inherited genetic mutations, and knowing about a mutation early gives individuals an opportunity to work with their healthcare provider to develop a personalized screening and prevention plan.[1, 2, 3, 4] The National Cancer Institute has shown that the 5-year survival rate for breast cancer that is caught late is 25%, whereas the survival rate increases to 98% when the cancer is caught at an earlier and more treatable stage.
In our continued effort to democratize access to important genetic information, we hope that the Breast Cancer Awareness Month pricing will further reduce barriers for members of our community who could benefit from knowing this information.